Fontana, Pierre

 
Title Year Hits Downloads
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model 2018 49 2
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT 2018 31 1
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A. 2017 33 0
Impact of rivaroxaban on point-of-care assays 2017 48 0
TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells 2017 68 2
Platelets in liver regeneration 2017 35 1
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 2017 63 0
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring 2017 51 8
Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function 2017 61 29
Impact of pneumatic tube system transport for the monitoring of heparin therapy 2017 29 0
Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients 2017 80 1
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? 2017 35 0
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study 2017 29 0
Platelet reactivity in stable cardiovascular patients with chronic kidney disease 2017 62 0
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system 2017 77 3
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels 2017 32 0
Angiologie et hémostase 2017 35 21
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation 2017 36 0
News in angiology and hemostasis 2016 180 72
Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential 2016 150 3
Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model 2016 71 2
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data 2016 138 2
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study 2016 78 0
New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach 2016 205 6
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? 2016 119 49
Direct oral anticoagulants: a guide for daily practice 2016 283 133
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect 2016 43 22
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach 2016 141 87
La maladie thromboembolique veineuse : une pathologie souvent oubliée 2016 22 12
Pharmacogenomics of Oral Antithrombotic Drugs 2016 194 0
Genetics of clopidogrel poor-response 2016 108 0
Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne 2016 29 16
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies 2016 217 1
PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients 2016 80 0
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 236 98
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke 2016 86 0
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review 2015 206 4
The Human Diabetes Proteome Project (HDPP): The 2014 update 2015 89 55
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation 2015 128 8
Direct oral anticoagulants: efficacy and safety in patient subgroups 2015 251 153
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study 2015 172 0
Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor 2015 157 1
Reply to: "The role of platelets in liver regeneration - What don't we know?" 2015 72 0
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma 2015 112 77
Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator 2015 180 0
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants 2015 126 82
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? 2015 199 2
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? 2015 250 1
Laboratory testing of Hemostasis 2015 48 58
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins 2015 259 1
A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? 2015 211 0
Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation 2015 58 50
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 2014 235 1
Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study 2014 60 20
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood 2014 153 2
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. 2014 216 2
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism 2014 211 127
Antiplatelet Therapy: Targeting the TxA2 Pathway 2014 191 2
Role of paraoxonase-1 in CYP2C19 loss-of-function carriers 2014 220 0
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules 2014 313 3
Hémostase. Aspirine: une ou deux fois par jour? 2014 255 2
How to manage prasugrel and ticagrelor in daily practice 2014 77 86
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies 2014 196 0
Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays 2014 299 1
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 2013 160 0
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management 2013 213 0
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm 2013 227 214
Gestion péri-interventionnelle des nouveaux agents antiplaquettaires 2013 226 131
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping 2013 129 0
Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique 2013 56 0
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention 2013 209 14
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? 2013 196 1
Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? 2013 213 1
Aspirin for venous thromboembolism prevention and treatment: a renewal? 2012 196 98
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro 2012 154 0
Platelet proteomics 2012 192 2
Prevalence of poor biological response to clopidogrel: a systematic review 2012 139 0
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis 2012 201 0
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study 2012 219 3
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management 2012 208 0
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin 2011 194 0
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study 2011 203 0
Connexin 37 limits thrombus propensity by downregulating platelet reactivity 2011 259 365
Surveillance biologique des héparines et du fondaparinux 2011 207 2
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients 2011 229 1
Antiagregants plaquettaires : lequel, quand et pour qui ? 2010 179 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study 2010 198 0
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis 2010 130 0
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? 2010 149 0
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique 2010 212 0
Hémostase. Le point sur les nouveaux antithrombotiques 2010 196 0
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability 2010 234 0
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? 2009 175 0
Intercellular communication in atherosclerosis 2009 204 0
No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro 2009 183 0
Diagnosis of mild bleeding disorders 2009 246 922
Cell-derived microparticles in haemostasis and vascular medicine 2009 190 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance 2009 136 0
Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique 2009 199 0
Assessing aspirin responsiveness using the Verify Now Aspirin assay 2008 220 1
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis 2008 226 1
Laboratory-defined aspirin resistance and recurrent cardiovascular events 2008 201 0
Aspirin "resistance" and risk of cardiovascular morbidity 2008 173 1
Aspirin response variability assessed with the PFA-100 device 2008 212 0
Impending paradoxical embolism. When and how to treat? 2008 214 1
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness 2008 186 0
16271 3067